NUCB1 and pancreatic ductal adenocarcinoma: Moreover, data mining in the UALCAN database (http://ualcan.path.uab.edu/analysis.html; accessed on 1 July 2022) revealed that downregulation of NUCB1 correlates with a worse prognosis for patients with pancreatic ductal adenocarcinoma (PDAC) [99], while our analysis showed the opposite effects in DLBCL.